© Copyright 2012, vLex. All Rights Reserved.
- Language
Contents in vLex United States
Explore vLex
For Professionals
For Partners
Company
Journal of Drugs in Dermatology
COPYRIGHT Journal of Drugs in Dermatology, Inc.
COPYRIGHT GALE, Cengage Learning. All rights reserved
from December 2002
Last Number: April 2012
ISSN 1545-9616
All the contents
ALA-PDT and blue light therapy for hidradenitis suppurativa.
Articles
Effectiveness and safety of ALA-IPL in treating actinic keratoses and photodamage.
Articles
Articles
Photodynamic therapy comes of age.
Foreword
Photodynamic therapy in dermatology: history and horizons.
Articles
A letter from the Editor-in-Chief.
Letters to the Editor - Letter to the Editor
Diphenhydramine gargling may slow the healing of oral lesions of pemphigus vulgaris.
Letters to the Editor - Letter to the Editor
Redefining clinical response in psoriasis: targeting the pathological basis of disease.
Articles
Topical treatment of actinic keratosis with fluorouracil: is irritation associated with efficacy?
Articles
Articles
Photorejuvenation with Intense Pulsed Light: results of a multi-center study.
Articles
Onychomycosis: classification and diagnosis.
Articles
Picaridin: a new insect repellent.
Articles
Dermatologic look- or sound-alike medications.
Articles
The nuances of dealing with cosmetic patients.
Focus on: Cosmetic Patients
Imiquimod as a possible treatment for keratoacanthoma.
Case Reports
Localized heat induced urticaria: report of a case.
Case Reports
Generalized pustular psoriasis following with-drawal of efalizumab.
Case Reports
Cutaneous vasculitis secondary to ramipril.
Case Reports
Case Reports
Primary cutaneous B-cell lymphoma in a 74-year-old Caucasian male.
Case Reports
Genetic testing for inherited predisposition to melanoma: has the time come?
Skin Cancer Foundation Update
Dalbavancin enters Phase III clinical trial in the treatment of skin infections.
Pipeline Previews
Provectus advances its development of Xantryl for the treatment of psoriasis.
Pipeline Previews
Recombinant alpha-1-antitrypsin gel studied for the treatment of atopic dermatitis.
Pipeline Previews
Riquent reduces lupus antibodies believed to cause renal disease.
Pipeline Previews
Abbott expands trial of its drug Humira in the treatment of psoriatic arthritis.
Pipeline Previews
ILX-651 enters Phase II studies in patients with metastatic melanoma.
Pipeline Previews